Mukhammadali Jumayev

Работ: 4

5th-year student, General Medicine Bukhara University of Innovative Education and Medicine

1. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

   Mukhammadali Jumayev

   СтатьяDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005208

2. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

   Mukhammadali Jumayev

   СтатьяDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005264

3. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

   Mukhammadali Jumayev

   СтатьяDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005352

4. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance

   Mukhammadali Jumayev

   СтатьяDiabetes Treatment and ManagementZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005357